Aspirin-induced asthma: advances in pathogenesis and management.
about
Challenges and Current Efforts in the Development of Biomarkers for Chronic Inflammatory and Remodeling Conditions of the LungsThe leukotriene C(4) synthase gene and asthmaSafety of selective COX-2 inhibitors in aspirin/nonsteroidal anti-inflammatory drug-intolerant patients: comparison of nimesulide, meloxicam, and rofecoxibPolymorphisms in the prostaglandin E2 receptor subtype 2 gene confer susceptibility to aspirin-intolerant asthma: a candidate gene approachAspirin-sensitive asthmaCOX-1 sparing drugs in aspirin-sensitive asthmaSafety of a specific COX-2 inhibitor in aspirin-induced asthmaCysteinyl-leukotriene release test (CAST) in the diagnosis of immediate drug reactionsSerum interleukin-5 in aspirin-induced asthmaRelease of cysteinyl leukotrienes with aspirin stimulation and the effect of prostaglandin E(2) on this release from peripheral blood leucocytes in aspirin-induced asthmatic patientsImprovement of aspirin-intolerant asthma by montelukast, a leukotriene antagonist: a randomized, double-blind, placebo-controlled trialAspirin-sensitive versus non-aspirin-sensitive nasal polyp patients: analysis of leukotrienes/Fas and Fas-ligand expressionA new insight into aspirin-induced asthmaDecreased apoptosis and distinct profile of infiltrating cells in the nasal polyps of patients with aspirin hypersensitivityFailure of montelukast to prevent aspirin-induced asthmaThe prevalence of aspirin intolerant asthma (AIA) in Australian asthmatic patientsNasal provocation test (NPT) with aspirin: a sensitive and safe method to diagnose aspirin-induced asthma (AIA)Complement C3a and C4a increased in plasma of patients with aspirin-induced asthmaIncreased exhaled cysteinyl-leukotrienes and 8-isoprostane in aspirin-induced asthmaAsthma, nasal polyposis and ulcerative colitis: a new perspectiveLeukotriene modifiers to prevent aspirin-provoked respiratory reactions in asthmaticsThe safety of celecoxib in patients with aspirin-sensitive asthmaA comparative study of eicosanoid concentrations in sputum and urine in patients with aspirin-intolerant asthmaThe effect of leukotriene-modifier drugs on aspirin-induced asthma and rhinitis reactionsBronchial mast cells are the dominating LTC4S-expressing cells in aspirin-tolerant asthmaCysteinyl leukotriene receptor 1 promoter polymorphism is associated with aspirin-intolerant asthma in malesAssociation of TNF-alpha genetic polymorphism with HLA DPB1*0301Mechanisms of aspirin-sensitive respiratory disease--a two-compartment modelSevere asthma attacks after sexual intercourseCysteinyl leukotriene receptor expression in aspirin-sensitive nasal polyposis patientsClinical profile of patients with adult-onset eosinophilic asthmaNational Athletic Trainers' Association position statement: management of asthma in athletes.Eosinophils and Mast Cells in Aspirin-Exacerbated Respiratory Disease.Factors driving the aspirin exacerbated respiratory disease phenotype.Aspirin activation of eosinophils and mast cells: implications in the pathogenesis of aspirin-exacerbated respiratory diseaseChronic rhinosinusitis and antibiotics: the good, the bad, and the ugly.Interleukin-4 in the Generation of the AERD Phenotype: Implications for Molecular Mechanisms Driving Therapeutic Benefit of Aspirin Desensitization.Intranasal challenge with aspirin in the diagnosis of aspirin intolerant asthma: evaluation of nasal response by acoustic rhinometry.Clinical features and diagnosis of aspirin induced asthma.Genetics of aspirin induced asthma.
P2860
Q26766294-209A8E43-B9AF-46CD-9B48-971BF6FDD891Q28145246-5A0689B4-7AEA-49D7-9ADF-401CC6E94698Q28168018-9170F745-070F-43CB-8585-119ACC40B5DCQ28171243-1D0384AD-A3A4-41CC-9A7C-BA49DB4BCB36Q28174122-0DE393DE-A815-46A3-BE40-EEA3363D339BQ28177176-EFF9B4AD-ED86-4A75-9B21-CDBE0EF27A79Q28177184-190D5D66-5DED-42E5-B93E-5942558310E3Q28185618-E0FA6EAE-A688-43E9-B761-80BE2DB38947Q28186724-6758B848-5719-4463-8DA7-B58A8677B983Q28190812-B7B81475-8A20-4E4B-8502-E94741E5A70DQ28192038-0BFBD728-0F3A-40FF-8340-8E93808D90B4Q28192447-29B54231-03EF-4133-A238-D67C46954018Q28192535-43E988A9-5675-474A-B895-2448166940E1Q28193060-737FC997-D4F6-48BA-A071-9C7D1AA53020Q28193093-D4021075-6B29-4331-93F5-245A58ECEF63Q28193330-A66F371C-C617-4773-909B-34160D21481AQ28193349-275DDA32-E669-4C8A-9CB5-A4E37BE04500Q28193417-7474A81B-69D9-4814-AFBF-9EB92CB0BDA8Q28193535-9F43B029-E9FC-4FFB-BEE0-F00786A7F7BAQ28193641-192CCB13-3DA0-4C88-BEA8-5FB1794D7D55Q28193652-494B8D04-76EE-458F-980F-F9BA38CFF01BQ28193684-0DA7DD6A-30D2-4D4E-B399-CB5D5C97609CQ28193908-4D214B08-C634-4A0A-AF41-D7AA8E4B0527Q28193909-BE481496-F279-4AE8-BC3C-DCBF118DB04BQ28196491-1C750674-0CDC-427C-90FA-398B56B14709Q28196697-F611226B-2488-457D-B7AC-43CBCCBA6B41Q28200594-F6A73462-0D98-411D-8E71-09299015EEB4Q28200600-5614153E-19A3-488E-AD9F-6FD5E5744FF9Q28209778-8C33143A-C292-4626-B2F6-B56095DDBE04Q28218553-E6AC6D82-DE62-4D16-83E7-8FE782A04E22Q28596640-1A891A76-073D-4BAB-AF75-951392AF5AEAQ28769235-9C492FB4-DD7A-4ED4-BDDE-916D744A090BQ30275780-C39ECCE7-8709-4FFC-8F77-E05550D7B8E4Q30300955-743581B3-4924-49B5-8626-11D224A5D8F2Q30384450-0CDF9D57-492B-4B3A-BC77-882C1B89A50FQ30416254-8DF4727F-665E-4858-A6B3-68A17C6CAE54Q30428747-AD9D41C7-4B97-4305-BE90-E9B9783B8B7DQ30496379-0B70B1EB-09F0-4964-8D0A-2B7B22E0D226Q34036215-59003948-4483-4637-884E-7958D45CC837Q34036221-9EE0EA23-356A-45EC-9551-2A5EE00266F9
P2860
Aspirin-induced asthma: advances in pathogenesis and management.
description
1999 nî lūn-bûn
@nan
1999 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Aspirin-induced asthma: advances in pathogenesis and management.
@ast
Aspirin-induced asthma: advances in pathogenesis and management.
@en
type
label
Aspirin-induced asthma: advances in pathogenesis and management.
@ast
Aspirin-induced asthma: advances in pathogenesis and management.
@en
prefLabel
Aspirin-induced asthma: advances in pathogenesis and management.
@ast
Aspirin-induced asthma: advances in pathogenesis and management.
@en
P1476
Aspirin-induced asthma: advances in pathogenesis and management.
@en
P2093
Stevenson DD
P356
10.1016/S0091-6749(99)70106-5
P407
P577
1999-07-01T00:00:00Z